DV
Dividend Vision

PCVX — Vaxcyte Inc.

Vaxcyte Inc. (PCVX)

Total return is 122.1% over the past 6.2 years, 56.2 points behind SPY at 178.3%. Its deepest 1-year drawdown was 28.0%.

Based on the data provided, this appears to be a single equity security rather than a diversified ETF. Vaxcyte Inc. is a biopharmaceutical company focused on vaccine development, classified as a stock holding with no dividend distribution history. The security does not generate dividend income and carries no expense ratio data typical of ETF structures, making it unsuitable for income-focused dividend investors seeking regular distributions.

PCVX key facts

Asset type
Stock
Asset class
Equity
Inception date
06/12/2020
Distribution frequency
None
Last close
$58.07
Market cap
$8,641,122,304
Average volume
656600.0
Beta
1.21
Payout ratio
0.0
Forward P/E
0.0
EPS
$-7.52